Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
ライセンスの購入
どんな用途に素材を使えますか?
¥38,500
JPY

詳細

制限:
商業目的またはプロモーション目的で使用する場合は、ゲッティ イメージズのオフィスへお問い合わせください。For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
クレジット:
Bloomberg / 寄稿者
報道写真番号:
452152892
コレクション:
Bloomberg
作成日:
2014年07月14日(月)
アップロード日:
ライセンスタイプ:
リリース情報:
リリースされていません。 詳細情報
ソース:
Bloomberg
オブジェクト名:
ABBOTT MYLAN